Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)
Condition:   Rhinitis, Allergic, SeasonalInterventions:   Biological: MK-3641;   Biological: Placebo;   Drug: Self-injectable epinephrine;   Drug: Albuterol/Salbutamol;   Drug: Loratadine;   Drug: Olopatadine;   Drug: Mometasone furoate monohydrateSponsor:   Merck Sharp & Dohme Corp.Not yet recruiting - verified June 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2015 Category: Research Source Type: clinical trials

Trial of AccuPAP Device Versus Standard Nebulizer Therapy in Acute Asthma Exacerbation in Children
Condition:   AsthmaInterventions:   Device: AccuPAP;   Drug: Albuterol and Ipratropium Continuous NebulizerSponsor:   Vanderbilt UniversityNot yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2015 Category: Research Source Type: clinical trials

Preterm Infant Inhaled Albuterol Dosing
Conditions:   Bronchopulmonary Dysplasia;   Very Low Birth WeightIntervention:   Drug: Varied albuterol dose responseSponsor:   Oregon Health and Science UniversityRecruiting - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 14, 2015 Category: Research Source Type: clinical trials

A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic ObstructiveInterventions:   Drug: Triple FF/UMEC/VI;   Drug: Placebo to match FF/UMEC/VI;   Drug: Budesonide/Formoterol;   Drug: Placebo to match Budesonide/Formoterol combination;   Drug: Albuterol/salbutamolSponsor:   GlaxoSmithKlineRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2015 Category: Research Source Type: clinical trials

A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic ObstructiveInterventions:   Drug: Triple FF/UMEC/VI;   Drug: Placebo to match FF/UMEC/VI;   Drug: Budesonide/Formoterol;   Drug: Placebo to match Budesonide/Formoterol combination;   Drug: Albuterol/salbutamolSponsor:   GlaxoSmithKlineRecruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2015 Category: Research Source Type: clinical trials

A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic ObstructiveInterventions:   Drug: Triple FF/UMEC/VI;   Drug: Placebo to match FF/UMEC/VI;   Drug: Budesonide/Formoterol;   Drug: Placebo to match Budesonide/Formoterol combination;   Drug: Albuterol/salbutamolSponsor:   GlaxoSmithKlineRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2015 Category: Research Source Type: clinical trials

A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic ObstructiveInterventions:   Drug: Triple FF/UMEC/VI;   Drug: Placebo to match FF/UMEC/VI;   Drug: Budesonide/Formoterol;   Drug: Placebo to match Budesonide/Formoterol combination;   Drug: Albuterol/salbutamolSponsor:   GlaxoSmithKlineRecruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2015 Category: Research Source Type: clinical trials

A Study to Evaluate the Effect of the Combination of Umeclidinium (UMEC) and Vilanterol (VI) on Exercise Endurance Time (EET) in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic ObstructiveInterventions:   Drug: UMEC/VI DPI;   Drug: Placebo DPI;   Drug: Albuterol/salbutamol MDISponsor:   GlaxoSmithKlineNot yet recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2014 Category: Research Source Type: clinical trials

A Study to Evaluate the Effect of the Combination of Umeclidinium (UMEC) and Vilanterol (VI) on Exercise Endurance Time (EET) in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic ObstructiveInterventions:   Drug: UMEC/VI DPI;   Drug: Placebo DPI;   Drug: Albuterol/salbutamol MDISponsor:   GlaxoSmithKlineNot yet recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2014 Category: Research Source Type: clinical trials

A Study to Evaluate the Effect of the Combination of Umeclidinium (UMEC) and Vilanterol (VI) on Exercise Endurance Time (EET) in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic ObstructiveInterventions:   Drug: UMEC/VI DPI;   Drug: Placebo DPI;   Drug: Albuterol/salbutamol MDISponsor:   GlaxoSmithKlineRecruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2014 Category: Research Source Type: clinical trials

A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic ObstructiveInterventions:   Drug: UMEC DPI;   Drug: Placebo DPI;   Drug: ICS/LABA medication;   Drug: Albuterol/salbutamol Metered Dose Inhaler (MDI)Sponsor:   GlaxoSmithKlineNot yet recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2014 Category: Research Source Type: clinical trials

Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium
Condition:   Pulmonary Disease, Chronic ObstructiveInterventions:   Drug: UMEC/VI;   Drug: UMEC/VI matching placebo;   Drug: Tiotropium;   Drug: Tiotropium matching placebo;   Drug: Indacaterol;   Drug: Indacaterol matching placebo;   Drug: Albuterol/salbutamol Metered Dose Inhaler (MDI)Sponsor:   GlaxoSmithKlineRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2014 Category: Research Source Type: clinical trials

A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic ObstructiveInterventions:   Drug: UMEC DPI;   Drug: Placebo DPI;   Drug: ICS/LABA medication;   Drug: Albuterol/salbutamol Metered Dose Inhaler (MDI)Sponsor:   GlaxoSmithKlineRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2014 Category: Research Source Type: clinical trials

Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium
Condition:   Pulmonary Disease, Chronic ObstructiveInterventions:   Drug: UMEC/VI;   Drug: UMEC/VI matching placebo;   Drug: Tiotropium;   Drug: Tiotropium matching placebo;   Drug: Indacaterol;   Drug: Indacaterol matching placebo;   Drug: Albuterol/salbutamol Metered Dose Inhaler (MDI)Sponsor:   GlaxoSmithKlineRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2014 Category: Research Source Type: clinical trials

A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic ObstructiveInterventions:   Drug: UMEC DPI;   Drug: Placebo DPI;   Drug: ICS/LABA medication;   Drug: Albuterol/salbutamol Metered Dose Inhaler (MDI)Sponsor:   GlaxoSmithKlineRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2014 Category: Research Source Type: clinical trials

A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic ObstructiveInterventions:   Drug: UMEC DPI;   Drug: Placebo DPI;   Drug: ICS/LABA medication;   Drug: Albuterol/salbutamol Metered Dose Inhaler (MDI)Sponsor:   GlaxoSmithKlineRecruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2014 Category: Research Source Type: clinical trials

Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium
Condition:   Pulmonary Disease, Chronic ObstructiveInterventions:   Drug: UMEC/VI;   Drug: UMEC/VI matching placebo;   Drug: Tiotropium;   Drug: Tiotropium matching placebo;   Drug: Indacaterol;   Drug: Indacaterol matching placebo;   Drug: Albuterol/salbutamol Metered Dose Inhaler (MDI)Sponsor:   GlaxoSmithKlineRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2014 Category: Research Source Type: clinical trials

Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium
Condition:   Pulmonary Disease, Chronic ObstructiveInterventions:   Drug: UMEC/VI;   Drug: UMEC/VI matching placebo;   Drug: Tiotropium;   Drug: Tiotropium matching placebo;   Drug: Indacaterol;   Drug: Indacaterol matching placebo;   Drug: Albuterol/salbutamol Metered Dose Inhaler (MDI)Sponsor:   GlaxoSmithKlineActive, not recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2014 Category: Research Source Type: clinical trials

A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic ObstructiveInterventions:   Drug: UMEC DPI;   Drug: Placebo DPI;   Drug: ICS/LABA medication;   Drug: Albuterol/salbutamol Metered Dose Inhaler (MDI)Sponsor:   GlaxoSmithKlineActive, not recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2014 Category: Research Source Type: clinical trials

Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium
Condition:   Pulmonary Disease, Chronic ObstructiveInterventions:   Drug: UMEC/VI;   Drug: UMEC/VI matching placebo;   Drug: Tiotropium;   Drug: Tiotropium matching placebo;   Drug: Indacaterol;   Drug: Indacaterol matching placebo;   Drug: Albuterol/salbutamol Metered Dose Inhaler (MDI)Sponsor:   GlaxoSmithKlineActive, not recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2014 Category: Research Source Type: clinical trials